J. Lapoirie

ORCID: 0000-0002-1881-5158
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Mast cells and histamine
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Acute Myeloid Leukemia Research
  • Systemic Sclerosis and Related Diseases
  • Autoimmune Bullous Skin Diseases
  • Autoimmune and Inflammatory Disorders
  • Platelet Disorders and Treatments
  • Viral Infections and Immunology Research
  • Blood groups and transfusion
  • Education, sociology, and vocational training
  • Drug-Induced Ocular Toxicity
  • Kruppel-like factors research
  • Cancer Immunotherapy and Biomarkers
  • Rabies epidemiology and control
  • Diagnosis and treatment of tuberculosis
  • T-cell and B-cell Immunology
  • Vasculitis and related conditions
  • Infectious Encephalopathies and Encephalitis
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Streptococcal Infections and Treatments
  • Cerebral Venous Sinus Thrombosis
  • Social Policies and Family
  • Blood disorders and treatments

Centre Hospitalier Agen - Nérac
2024

Centre Hospitalier Universitaire de Bordeaux
2017-2021

Hôpital Saint-André
2016-2021

Université de Bordeaux
2017-2020

Centre Hospitalier De Pau
2017

Hôpital Cardiologique du Haut-Lévêque
2017

Institute Cancer De La Loire Lucien Neuwirth
2013-2016

Cancer Institute (WIA)
2016

Introduction: Philadelphia-negative myeloproliferative neoplasms (MPNs) greatly increase the risk of maternal and fetal complications during pregnancy. Currently, international agreements regarding management these women are lacking.Patients methods: Our study aimed to assess current outcomes MPN pregnancies in a French cohort. We retrospectively analyzed 27 with MPNs that were associated specific mutation. Nineteen nine essential thrombocythemia eight five polycythemia vera...

10.1080/14767058.2018.1484097 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2018-06-26

To develop and test the feasibility of a tailored therapeutic educational program, with aim improving adherence to oral endocrine adjuvant chemotherapy in women breast cancer. .A qualitative study identify needs assessing efficacy program. comprehensive cancer center, Lucien Neuwirth Cancer Institute Saint-Priest-en-Jarez, France. .Two consecutive samples (N = 11, N 6) taking for mixed quantitative method was used. The participants' representations disease treatment were explored through...

10.1188/16.onf.e94-e103 article EN Oncology nursing forum 2016-04-22

To characterize the role of interleukin-1β (IL-1β) and microvascular endothelial cells (MVECs) in generation alternatively activated macrophages skin, to explore their development skin fibrosis patients with systemic sclerosis (SSc; scleroderma).Conditioned medium prepared MVECs purified from healthy donors SSc was used generate monocyte-derived macrophages. Flow cytometry, multiplex protein assessment, real-time quantitative polymerase chain reaction, tissue immunofluorescence were...

10.1002/art.42061 article EN Arthritis & Rheumatology 2021-12-28

Combination therapy with hydroxychloroquine and darunavir/ritonavir or lopinavir/ritonavir has been suggested as an approach to improve the outcome of patients moderate/severe COVID-19 infection.To examine safety combination lopinavir/ritonavir.This was observational cohort study hospitalized for pneumonia treated lopinavir/ritonavir. Clinical evaluations, electrocardiograms pharmacokinetics hydroxychloroquine, darunavir lopinavir were examined according clinical practice...

10.1093/jac/dkaa441 article EN other-oa Journal of Antimicrobial Chemotherapy 2020-11-16

Abstract Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by microangiopathy and fibrosis of the skin internal organs. No treatment has been proved to be efficient in case early or advanced SSc prevent reduce fibrosis. There are strong arguments for key role topo-I pathogenesis diffuse SSc. Irinotecan, semisynthetic derivative Camptothecin, specifically target topo-I. This study was undertaken evaluate effects noncytotoxic doses irinotecan its active...

10.1038/s41598-021-97538-3 article EN cc-by Scientific Reports 2021-09-09

10.1016/j.revmed.2021.03.079 article FR La Revue de Médecine Interne 2021-06-01
Coming Soon ...